Angelo Sangiovanni

10.3k citations
124 papers · 6.1k · 2 hit papers · h-index 36

Impact in

  • Hepatology top 0.1%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Hepatitis C virus research
  • Epidemiology top 0.5%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 59
    • Liver Disease and Transplantation 31
    • Hepatitis C virus research 23
    • Liver physiology and pathology 6
    • Liver Disease Diagnosis and Treatment 66
    • Hepatitis B Virus Studies 20

Angelo Sangiovanni

117 papers receiving 6.0k citations

Angelo Sangiovanni's Hit Papers

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial 2012 · 656 citations
6560+11+23Years since publication200400600

Peers

Angelo Sangiovanni
Comparison fields: 5 of 115
  • Hepatology 4.7k
  • Epidemiology 3.8k
  • Cancer Research 570
  • Oncology 752
  • Pathology and Forensic Medicine 460
Replace Nathalie Ganne‐Carrié with:
Nathalie Ganne‐Carrié France
Chae Yoon Chon South Korea
Moon Seok Choi South Korea
Kwang Cheol Koh South Korea
Yukio Osaki Japan
Jean–Claude Trinchet France
Byung Chul Yoo South Korea
Toshifumi Tada Japan
Matthias Pinter Austria
Massimo Colombo Italy
Angelo Sangiovanni relative to Nathalie Ganne‐Carrié France Nathalie Ganne‐Carrié's profile →
Citations per field
00.5×1.5×
Nathalie Ganne‐Carrié · 1×
Citations per year

Countries citing papers authored by Angelo Sangiovanni

Since Specialization
Citations

This map shows the geographic impact of Angelo Sangiovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Sangiovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Sangiovanni more than expected).

Fields of papers citing papers by Angelo Sangiovanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Sangiovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Sangiovanni. The network helps show where Angelo Sangiovanni may publish in the future.

Co-authors

The 25 scholars most cited alongside Angelo Sangiovanni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angelo Sangiovanni Line = papers co-authored together Angelo Sangiovanni links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Hit paper breakdown →
2012656
2
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Hit paper breakdown →
1991649
3 2004457
4 2006438
5 2001334
6 2009294
7 2009236
8 2008220
9 2013158
10 2000138
11 2014109
12 2010105
13 2001103
14 201592
15 201392
16 201387
17 201584
18 201883
19 198983
20 199873

About Angelo Sangiovanni

Angelo Sangiovanni is a scholar working on Hepatology, Epidemiology, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 124 papers that have together received 6.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (66 papers), Hepatocellular Carcinoma Treatment and Prognosis (59 papers), Liver Disease and Transplantation (31 papers), Hepatitis C virus research (23 papers), Hepatitis B Virus Studies (20 papers), Liver physiology and pathology (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Hepatology (4.7k citations), Epidemiology (3.8k citations), Cancer Research (570 citations), Oncology (752 citations) and Pathology and Forensic Medicine (460 citations). Angelo Sangiovanni has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include E. Del Ninno, Massimo Colombo, R. Romeo, Roberto de Franchis, Massimo Iavarone, Guido Ronchi, Cristina De Fazio, Pierangelo Fasani, M. Colombo and Massimo Colombo. Their work appears in journals such as Journal of Hepatology, Digestive and Liver Disease, Liver International, Hepatology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact